These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 20573255)
1. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Yee DS; Tang Y; Li X; Liu Z; Guo Y; Ghaffar S; McQueen P; Atreya D; Xie J; Simoneau AR; Hoang BH; Zi X Mol Cancer; 2010 Jun; 9():162. PubMed ID: 20573255 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling. Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132 [TBL] [Abstract][Full Text] [Related]
3. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway. Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674 [TBL] [Abstract][Full Text] [Related]
4. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305 [TBL] [Abstract][Full Text] [Related]
5. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1. Sun B; Fan Y; Yang A; Liang L; Cao J J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493 [TBL] [Abstract][Full Text] [Related]
7. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. Bhat FA; Sharmila G; Balakrishnan S; Arunkumar R; Elumalai P; Suganya S; Raja Singh P; Srinivasan N; Arunakaran J J Nutr Biochem; 2014 Nov; 25(11):1132-1139. PubMed ID: 25150162 [TBL] [Abstract][Full Text] [Related]
8. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling. Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661 [TBL] [Abstract][Full Text] [Related]
9. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness. Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma. Yang SH; Li SL; Dong ZM; Kan QC Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918 [TBL] [Abstract][Full Text] [Related]
12. Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins. Huang Y; Du Q; Wu W; She F; Chen Y Mol Med Rep; 2016 Sep; 14(3):2573-81. PubMed ID: 27430608 [TBL] [Abstract][Full Text] [Related]
13. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Zi X; Guo Y; Simoneau AR; Hope C; Xie J; Holcombe RF; Hoang BH Cancer Res; 2005 Nov; 65(21):9762-70. PubMed ID: 16266997 [TBL] [Abstract][Full Text] [Related]
14. β-ionone Inhibits Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Cells by Negatively Regulating the Wnt/β-Catenin Pathway. Fang Q; Que T; Liu B; Dan W; Wei Y; Ren B; Fan Y; Hou T; Zeng J Front Biosci (Landmark Ed); 2022 Dec; 27(12):335. PubMed ID: 36624947 [TBL] [Abstract][Full Text] [Related]
15. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Chen L; Mai W; Chen M; Hu J; Zhuo Z; Lei X; Deng L; Liu J; Yao N; Huang M; Peng Y; Ye W; Zhang D Pharmacol Res; 2017 Sep; 123():130-142. PubMed ID: 28712972 [TBL] [Abstract][Full Text] [Related]
16. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells. Wang X; Xu J; Wang H; Wu L; Yuan W; Du J; Cai S Biochem Biophys Res Commun; 2015 Jan; 456(1):320-6. PubMed ID: 25434997 [TBL] [Abstract][Full Text] [Related]
17. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556 [TBL] [Abstract][Full Text] [Related]
18. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
19. Genistein inhibits invasion and migration of colon cancer cells by recovering WIF1 expression. Zhu J; Ren J; Tang L Mol Med Rep; 2018 May; 17(5):7265-7273. PubMed ID: 29568950 [TBL] [Abstract][Full Text] [Related]
20. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells. Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]